PKM and cancer: Several newly found PKM2 inhibitors with high cancer repression in vitro and mice xenograft models, such as Shikonin and Isovitexin (Zhao et al., 2018; Chen et al., 2021a), need more clinical trials to detect the efficiency and toxicity of PKM2 inhibition in complex internal environments.